Streetbeat News

Regulatory

FARM

Farmer Brothers (FARM) has received a letter from JCP Partnership nominating Troy A. Ellis, Emily K. Keeton, and David R. Tresko for election to the board at the annual meeting, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 8:18 pm

SYK

Shares of Stryker Corporation (NYSE:SYK) traded higher on Monday, rebounding from a fall last week following the FDA's establishment of a Digital Health Advisory Committee. The committee is intended to advise the FDA on topics related to digital health technologies. The stock began to rebound from the selloff last Friday, a move which continued on Monday.

Portfolio Pulse from Ryan Gustafson

October 16, 2023 | 8:18 pm

STRO

Sutro Biopharma, Inc. (NASDAQ:STRO), a clinical-stage oncology company, announced that it will have five presentations and one poster at the 14th Annual World ADC Conference in San Diego, October 16-19, 2023. The presentations will cover the development of next-generation ADCs, discovery of novel linker payloads, precision engineering for enhanced therapeutic index, stress-free ADC production, and preclinical development of STRO-003. The poster will discuss site-specific dual conjugation.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 8:06 pm

VTGN

Citadel Advisors LLC has reported a 5.6% stake in VistaGen Therapeutics, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 8:05 pm

ASND

Ascendis Pharma has presented 52-week results from the Phase 3 PaTHway Trial at ASBMR 2023. The results showed that the skeletal dynamics of adult patients with chronic hypoparathyroidism treated with TransCon PTH trended toward a new steady state closer to age-appropriate norms. Bone turnover markers trended toward the normal reference ranges for sex and menopausal status and corresponded to smaller changes in bone mineral density (BMD) through Week 52.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 8:03 pm

CMPS

CYBN

GHRS

MNMD

PSIL

Cybin Inc. (NYSE:CYBN) and Small Pharma Inc. (OTC:DMTTF) shareholders have approved the acquisition of the latter by the former. The FDA has issued a warning about the misuse of ketamine and ketamine-based drugs. The DEA has extended telemedicine flexibilities for controlled medications until the end of 2024. California Governor Gavin Newsom has vetoed a bill to decriminalize certain hallucinogens. Congress is discussing kratom product regulation. The AdvisorShares Psychedelics ETF (NYSE:PSIL) continues to show a downtrend in its opening price. Several psychedelic stocks, including GH Research (NASDAQ:GHRS), COMPASS Pathways (NASDAQ:CMPS), and Mind Medicine (NASDAQ:MNMD), also closed lower.

Portfolio Pulse from Lara Goldstein

October 16, 2023 | 7:57 pm

EIS

SPY

USO

Iran's Foreign Minister Amirabdollahian has stated that 'A Preemptive Actions' by the Resistance Front could be expected in the coming hours, according to Reuters citing Iran State TV.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:55 pm

HLTH

Oakmont Corp has reported a 6.3% stake in Cue Health as of October 6, 2023, according to a 13D filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:30 pm

ESTA

Establishment Labs has announced that the FDA has cleared its Motiva Flora SmoothSilk Tissue Expander, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:17 pm

SYK

Stryker shares are trading higher, possibly rebounding after a fall last week. The drop was due to the FDA establishing a Digital Health Advisory Committee.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:10 pm